Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
4.
Clin Exp Allergy ; 34(8): 1237-42, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15298564

ABSTRACT

BACKGROUND: Breast milk contains many immunomodulatory factors (soluble CD14 (sCD14), IgA and cytokines) with the potential to influence infant immune development. OBJECTIVE: To determine if changes in breast milk omega-3 polyunsaturated fatty acid (n-3 PUFA) composition as a result of maternal dietary fish oil supplementation during pregnancy can modify levels of these immunological parameters in breast milk. METHOD: In a randomized controlled trial, 83 atopic women received either 4 g fish oil capsules (containing 3.7 g n-3 PUFA) (n = 40) or 4 g olive oil capsules (n = 43) from 20 weeks gestation until delivery. Breast milk was collected 3 days post-partum and fatty acids were analysed by gas liquid chromatography and IgA, sCD14 and cytokines (IL-5, IL-6, IL-10, TNF-alpha and IFN-gamma) were quantitated by ELISA or time resolved fluorescence (TRF). RESULTS: Omega-3 docosahexaenoic acid (DHA; 22:6n-3) and eicosapentaenoic acid (EPA; 20:5n-3) levels were significantly higher (P < 0.001) in breast milk from women supplemented with fish oil (n = 33, DHA mean 1.15%, SD 0.47% and EPA mean 0.16%, SD 0.07%) than in samples from the control group (n = 40, DHA mean 0.50%, SD 0.17% and EPA mean 0.05%, SD 0.02%). Breast milk arachidonic acid (AA; 20:4n-6) levels were significantly lower (P = 0.045) in the fish oil group (mean 0.55%, SD 0.12%) compared with the control group (mean 0.61%, SD 0.14%). Breast milk IgA was positively correlated with DHA (P = 0.046) and 22:5n-3 (P = 0.003), but inversely correlated with linoleic acid (LA; 18:2n-6) (P=0.034). Levels of sCD14 were also positively correlated with 22:5n-3 (P=0.009). Cytokines involved in IgA synthesis (IL-10 and IL-6) were also significantly correlated with both IgA and n-3 PUFA levels, although there were no differences in the levels of breast milk IgA, sCD14 or cytokines between study groups. CONCLUSION: Supplementation with fish oil during pregnancy significantly alters early post-partum breast milk fatty acid composition. omega-3 PUFA levels were positively associated with IgA and sCD14 levels, suggesting a relationship between fatty acid status and mucosal immune function.


Subject(s)
Dietary Supplements , Fish Oils/administration & dosage , Hypersensitivity/immunology , Maternal Nutritional Physiological Phenomena , Milk, Human/immunology , Pregnancy Complications/immunology , Chi-Square Distribution , Cytokines/analysis , Double-Blind Method , Fatty Acids, Omega-3/analysis , Female , Humans , Immunoglobulin A/analysis , Lipopolysaccharide Receptors/analysis , Olive Oil , Plant Oils/administration & dosage , Pregnancy
7.
Exp Physiol ; 84(2): 435-47, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10226183

ABSTRACT

Quantitative measurements were made of relative breast volume and milk production from 1 month of lactation until 3 months after weaning, and the storage capacity of the breasts was calculated. The increase in breast tissue volume from before conception until 1 month of lactation was maintained for the first 6 months of lactation (means+/-S.E.M.) (190.3+/-13.1 ml, number of breasts, nb = 46). During this period of exclusive breast-feeding, 24 h milk production from each breast remained relatively constant (453.6+/-201 g, nb = 48), and storage capacity was 209.9+/-11.0 ml (nb = 46). After 6 months, breast volume, milk production and storage capacity all decreased. There was a relationship between 24 h milk production and the storage capacity of the breasts, and these both appeared to be responding to infant demand for milk. At 15 months of lactation, the 24 h milk production of each breast was substantial (208.0+/-56.7 g, nb = 6), even though the breasts had returned to preconception size. This was associated with an apparent increased efficiency of the breast (milk production per unit breast tissue) after 6 months, which may have been due to redistribution of tissues within the breast. The possible causes of the decrease in breast volume are discussed.


Subject(s)
Breast/anatomy & histology , Lactation/physiology , Adult , Body Weight/physiology , Breast/physiology , Fatty Acids/metabolism , Female , Humans , Infant , Infant, Newborn , Milk, Human/physiology , Time Factors
8.
Lipids ; 33(10): 1043-9, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9832086

ABSTRACT

An enzymatic assay for the determination of nonesterified fatty acid concentrations in milk and plasma is described. The procedure is semiautomated for use with a plate luminometer or plate spectrophotometer and enables routine batch processing of large numbers of small samples (< or =5 microL). Following the activation of nonesterified fatty acids (NEFA) by acylCoA synthetase, the current assay utilizes UDP-glucose pyrophosphorylase to link inorganic pyrophosphate to the production of NADH through the reactions catalyzed by phosphoglucomutase and glucose-6-phosphate 1-dehydrogenase. With this assay sequence the formation of NADH from NEFA is complete within 50 min at 37 degrees C. Enzymatic spectrophotometric techniques were unsuitable for NEFA determination in human milk due to the opacity of the sample. The use of the NADH-luciferase system has overcome this problem, allowing the enzymatic determination of NEFA in human milk. Sample collection and treatment procedures for milk and plasma have been developed to prevent enzymatic lipolysis and to limit interference from enzymes present in milk. The recovery of palmitic acid added to milk and plasma samples was 94.9+/-2.9 and 100+/-4.5%, respectively. There was no difference (P = 0.13) in plasma NEFA concentrations determined by the current method and a commercially available enzymatic spectrophotometric technique (Wako NEFA-C kit). Plasma NEFA concentrations determined by gas chromatography were 28% higher compared to both the Wako NEFA-C kit and the current method.


Subject(s)
Biochemistry/methods , Fatty Acids, Nonesterified/analysis , Milk/chemistry , Repressor Proteins , Saccharomyces cerevisiae Proteins , Animals , Automation , Coenzyme A Ligases/chemistry , Coenzyme A Ligases/metabolism , Fatty Acids, Nonesterified/blood , Female , Humans , Luciferases/chemistry , Luciferases/metabolism , Luminescent Measurements , NAD/metabolism , Reproducibility of Results , Specimen Handling , Spectrophotometry/methods , UTP-Glucose-1-Phosphate Uridylyltransferase/chemistry , UTP-Glucose-1-Phosphate Uridylyltransferase/metabolism
9.
J Nutr ; 128(2 Suppl): 394S-399S, 1998 02.
Article in English | MEDLINE | ID: mdl-9478034

ABSTRACT

Apart from the metabolic differences between species (ruminant vs. nonruminant), there are other important physiologic differences in both the energy requirements for lactation and in the control of milk production between dairy cows and women. Unlike dairy cows, the partitioning of nutrients for lactation in women therefore cannot be generalized to all lactating women but must be related to individual women, taking into account their particular metabolic circumstances. Homeorhetic models may be appropriate for women in developing countries, whereas in developed countries, the flexibility in both homeostatic and homeorhetic adaptations to the substrate demands for milk synthesis means that women can adopt a variety of strategies to support the metabolic demands of lactation. In these women, as in dairy cows, body reserves, dietary intake and milk production vary widely among individuals, and individual differences in capacity for homeorhetic regulation of nutrient partitioning under these conditions require further investigation.


Subject(s)
Energy Metabolism/physiology , Lactation/physiology , Milk/metabolism , Oxidative Stress/physiology , Animals , Female , Homeostasis , Humans , Milk/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...